Bacillus Coagulans market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacillus Coagulans market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type Below 100 B 100-200 B Above 200 B The classification of Bacillus Coagulans includes Below 100 B, 100-200 B and Above 200 B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2019 is about 47%. Segment by Application Drugs Food and Beverage Supplement Products Bacillus Coagulans is widely used in Drugs, Food and Beverage, Supplement Products and others. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2019 is 36%. In addition, the proportion of Food and Beverage in 2019 is 34%. By Company Kerry Sabinsa Mitsubishi UAS Laboratories Synbiotech Syngen Biotech Sanzyme Microbax By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia
1 Study Coverage 1.1 Bacillus Coagulans Product Introduction 1.2 Market by Type 1.2.1 Global Bacillus Coagulans Market Size Growth Rate by Type 1.4.2 Below 100 B 1.4.3 100-200 B 1.2.4 Above 200 B 1.3 Market by Application 1.3.1 Global Bacillus Coagulans Market Size Growth Rate by Application 1.3.2 Drugs 1.3.3 Food and Be